SCHEMBL15933652

SCHEMBL15933652

COc1ccccc1Oc1ccc(CF)cc1C(=O)Nc1ccc(C(=O)O)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15933510 0.92 — —
SCHEMBL15933731 0.90 P4HTM (0.52) —
SCHEMBL15933723 0.89 P4HTM (0.57) —
SCHEMBL15933727 0.89 P4HTM (0.52) —
SCHEMBL15933729 0.88 — —
SCHEMBL15933721 0.88 P4HTM (0.54) —
SCHEMBL15933730 0.86 — —
SCHEMBL15933728 0.85 — —
SCHEMBL15917994 0.84 — —
SCHEMBL15933700 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108903-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-08-18 — — US disclosed
US-20140221435-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
Send feedback